[go: up one dir, main page]

WO2012164488A3 - New cosmetic or dermopharmaceutical topical use of a mixture of a ghk tripeptide and gqpr tetrapeptide - Google Patents

New cosmetic or dermopharmaceutical topical use of a mixture of a ghk tripeptide and gqpr tetrapeptide Download PDF

Info

Publication number
WO2012164488A3
WO2012164488A3 PCT/IB2012/052681 IB2012052681W WO2012164488A3 WO 2012164488 A3 WO2012164488 A3 WO 2012164488A3 IB 2012052681 W IB2012052681 W IB 2012052681W WO 2012164488 A3 WO2012164488 A3 WO 2012164488A3
Authority
WO
WIPO (PCT)
Prior art keywords
gqpr
tetrapeptide
mixture
dermopharmaceutical
topical use
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/IB2012/052681
Other languages
French (fr)
Other versions
WO2012164488A2 (en
Inventor
Arnaud Fournial
Philippe Mondon
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sederma SA
Original Assignee
Sederma SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sederma SA filed Critical Sederma SA
Priority to EP12726879.5A priority Critical patent/EP2714001A2/en
Publication of WO2012164488A2 publication Critical patent/WO2012164488A2/en
Anticipated expiration legal-status Critical
Publication of WO2012164488A3 publication Critical patent/WO2012164488A3/en
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/06—Tripeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/07—Tetrapeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Dermatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Birds (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Cosmetics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)

Abstract

According to the invention, a mixture of A-GHK-B tripeptide and A-GQPR-B tetrapeptide (SEQ ID NO: 1), or their derivatives or analogs, for the therapeutical treatment of the papillary dermis, with: A = H, CO-R1, SO2-R1; B = OH, OR1, NH2, NHR1, NR1R2; R1 and R2 being, independently of one another, selected from an alkyl, aryl, aralkyl, alkylaryl, alkoxy and aryloxy group, which may be linear, branched, cyclic, polycyclic, unsaturated, hydroxylated, carbonylated, phosphorylated and/or sulfured, said group which may have a heteroatom in its skeleton including O, S and/or N; is used to prevent damage to the papillary dermis and/or repair the dermis papillary, to prevent and/or treat skin aging, in particular photo-induced aging.
PCT/IB2012/052681 2011-06-01 2012-05-29 New cosmetic or dermopharmaceutical topical use of a mixture of a ghk tripeptide and gqpr tetrapeptide Ceased WO2012164488A2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
EP12726879.5A EP2714001A2 (en) 2011-06-01 2012-05-29 New cosmetic or dermopharmaceutical topical use of a mixture of a ghk tripeptide and gqpr tetrapeptide

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR1154834 2011-06-01
FR1154834A FR2975904B1 (en) 2011-06-01 2011-06-01 NOVEL TOP USE, COSMETIC OR DERMOPHARMACEUTICAL, OF A MIXTURE COMPRISING A GHK TYPE TRIPEPTIDE AND A GQPR TYPE TETRAPEPTIDE

Publications (2)

Publication Number Publication Date
WO2012164488A2 WO2012164488A2 (en) 2012-12-06
WO2012164488A3 true WO2012164488A3 (en) 2014-01-23

Family

ID=46246124

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/IB2012/052681 Ceased WO2012164488A2 (en) 2011-06-01 2012-05-29 New cosmetic or dermopharmaceutical topical use of a mixture of a ghk tripeptide and gqpr tetrapeptide

Country Status (3)

Country Link
EP (1) EP2714001A2 (en)
FR (1) FR2975904B1 (en)
WO (1) WO2012164488A2 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9375398B2 (en) 2013-03-13 2016-06-28 Neocutis S.A. Peptides for skin rejuvenation and methods of using the same

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2014209910A1 (en) * 2013-06-24 2014-12-31 Sand Bruce J Transepidermal composition for restoration of pre-mature aging skin
CN103665102B (en) * 2013-12-31 2016-02-10 陕西东大生化科技有限责任公司 A kind of synthetic method of GHK tripeptide
FR3020946B1 (en) * 2014-05-13 2017-09-22 Universkin NEW EXTERNAL COSMETIC AND / OR DERMATOLOGICAL PREPARATIONS
HK1257429A1 (en) 2016-02-04 2019-10-18 ALASTIN Skincare, Inc. Compositions and methods for invasive and non-invasive procedural skincare
KR102757675B1 (en) 2017-08-03 2025-01-20 앨러스틴 스킨케어, 인크. Compositions and methods for skin relaxation and improvement of body contour
WO2020028694A1 (en) 2018-08-02 2020-02-06 ALASTIN Skincare, Inc. Liposomal compositions and methods of use
CN111004304B (en) * 2019-12-31 2020-11-10 山东济肽生物科技有限公司 Liquid phase synthesis method of biotin tripeptide-1
DE102020201019A1 (en) 2020-01-29 2021-07-29 Beiersdorf Aktiengesellschaft Allergen protection for the skin
FR3107708B1 (en) 2020-02-28 2025-03-07 Alganelle Recombinant microalgae capable of producing KTTKS peptides, polypeptides and proteins and their derivatives, and their associated methods and uses
FR3108258B1 (en) 2020-03-20 2022-08-05 Sederma Sa Cosmetic composition and treatment for treating sagging skin
US11571378B2 (en) 2021-01-22 2023-02-07 The Procter & Gamble Company Skin care composition and method of using the same
US11771637B2 (en) 2021-01-22 2023-10-03 The Procter & Gamble Company Skin care composition and method of using the same
WO2022157587A1 (en) * 2021-01-23 2022-07-28 Cellix Bio Private Limited A composition comprising lidocaine, l-carnosine and dexpanthenol
WO2024092334A1 (en) * 2022-10-31 2024-05-10 Chemyunion Ltda Compounds and cosmetic, dermocosmetic, cosmeceutical or pharmaceutical compositions for relaxing muscles, including the skeletal muscles of the face, for anti-aging cosmetic action, for reducing and/or smoothing expression lines and wrinkles and/or for antiperspirant action, uses and methods
WO2025067418A1 (en) * 2023-09-27 2025-04-03 深圳众格生物科技有限公司 Straight chain peptide compound and use thereof
WO2025215346A1 (en) * 2024-04-08 2025-10-16 The Boots Company Plc Skin wound treatment
WO2025215348A1 (en) * 2024-04-08 2025-10-16 The Boots Company Plc Skin wound treatment
WO2025215347A1 (en) * 2024-04-08 2025-10-16 The Boots Company Plc Skin wound treatment

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040132667A1 (en) * 2003-11-17 2004-07-08 Sederma S.A.S Compositions containing mixtures of tetrapeptides and tripeptides
DE102006046076A1 (en) * 2005-10-14 2007-04-19 Henkel Kgaa Cosmetic or dermatological topical composition contains oligopeptide derivative and apple extract, useful for treating e.g. wrinkles, creases and aging
US20070237735A1 (en) * 2006-03-31 2007-10-11 Laboratoires Dermo-Cosmetik Inc. Anti-aging composition, kit and method of use

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9220667D0 (en) 1992-09-30 1992-11-11 Unilever Plc Improvements in or relating to dioic acids
FR2821086B1 (en) 2001-02-21 2003-12-12 Sederma Sa PROCESS FOR THE MANUFACTURE OF PROTEINS BY FERMENTATION OF MICROORGANISMS OF THE THERMUS FAMILY, MIXTURE OF PROTEINS THUS OBTAINED AND COSMETIC COMPOSITION CONTAINING THEM
FR2830195B1 (en) 2001-10-03 2004-10-22 Sederma Sa COSMETIC AND DERMOPHARMACEUTICAL COMPOSITIONS FOR SKINS WITH ACNE TREND
FR2836042B1 (en) 2002-02-15 2004-04-02 Sederma Sa COSMETIC OR DERMOPHARMACEUTICAL COMPOSITIONS FOR REDUCING POCKETS AND DARK CIRCLES UNDER EYES
FR2843963B1 (en) 2002-08-30 2004-10-22 Sederma Sa NEW NORAPORPHIN-DERIVED MOLECULES
FR2854897B1 (en) 2003-05-12 2007-05-04 Sederma Sa COSMETIC OR DERMOPHARMACEUTICAL COMPOSITIONS FOR REDUCING THE SIGNS OF SKIN AGING.
FR2869229B1 (en) 2004-04-26 2006-08-25 Sederma Soc Par Actions Simpli USE OF A INDUCER OF UGT BY TOPIC
US7236897B2 (en) 2004-08-10 2007-06-26 Analog Devices, Inc. Group metering system for power meters
FR2880802B1 (en) 2005-01-14 2008-12-19 Sederma Soc Par Actions Simpli COSMETIC OR DERMOPHARMACEUTICAL COMPOSITION CONTAINING EUGLENE EXTRACT
US20090110573A1 (en) 2007-10-26 2009-04-30 Hoyt Robert A Apparatus and Method for Retaining and Isolating Modular Fan and Motor Sub-Assemblies in Air Moving Systems

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040132667A1 (en) * 2003-11-17 2004-07-08 Sederma S.A.S Compositions containing mixtures of tetrapeptides and tripeptides
DE102006046076A1 (en) * 2005-10-14 2007-04-19 Henkel Kgaa Cosmetic or dermatological topical composition contains oligopeptide derivative and apple extract, useful for treating e.g. wrinkles, creases and aging
US20070237735A1 (en) * 2006-03-31 2007-10-11 Laboratoires Dermo-Cosmetik Inc. Anti-aging composition, kit and method of use

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
FRANCESCO LACARRUBBA ET AL: "Mesotherapy for skin rejuvenation: assessment of the subepidermal low-echogenic band by ultrasound evaluation with cross-sectional B-mode scanning", DERMATOLOGIC THERAPY, vol. 21, November 2008 (2008-11-01), pages S1 - S5, XP055020933, ISSN: 1396-0296, DOI: 10.1111/j.1529-8019.2008.00234.x *

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9375398B2 (en) 2013-03-13 2016-06-28 Neocutis S.A. Peptides for skin rejuvenation and methods of using the same
US10543195B2 (en) 2013-03-13 2020-01-28 Anteis Sa Peptides for skin rejuvenation and methods of using the same
US11331305B2 (en) 2013-03-13 2022-05-17 Anteis Sa Peptides for skin rejuvenation and methods of using the same

Also Published As

Publication number Publication date
WO2012164488A2 (en) 2012-12-06
FR2975904B1 (en) 2013-08-23
FR2975904A1 (en) 2012-12-07
EP2714001A2 (en) 2014-04-09

Similar Documents

Publication Publication Date Title
WO2012164488A3 (en) New cosmetic or dermopharmaceutical topical use of a mixture of a ghk tripeptide and gqpr tetrapeptide
WO2009094172A3 (en) Tissue protective peptides and peptide analogs for preventing and treating diseases and disorders associated with tissue damage
PH12013501213A1 (en) Cyclosporine analogue molecules modified at amino acid 1 and 3
NI201300130A (en) COMPOSITIONS CONTAINING, METHODS INVOLVING, AND USES OF DOLASTATIN DERIVATIVES LINKED TO NON-NATURAL AMINO ACIDS
TW200833365A (en) Neuronal exocytosis inhibiting peptides
NZ602845A (en) Inhibiting peptides derived from trem-like transcript 1 (tlt-1) and uses thereof
EA201490809A1 (en) METHODS AND COMPOSITIONS FOR THE TREATMENT OF NON-EFFECTIVE ERYTHROPOESIS
WO2012143364A3 (en) Cosmetic composition for use in increasing collagen synthesis in skin cells
WO2010120431A3 (en) Methods for the prevention and treatment of burn injuries and secondary complications
ATE544775T1 (en) PEPTIDES WITH PHARMACOLOGICAL ACTIVITY FOR THE TREATMENT OF DISEASES ASSOCIATED WITH ALTERED CELL MIGRATION, SUCH AS CANCER
EP4285994A3 (en) Methods for the prevention or treatment of no-reflow following ischemia/reperfusion injury
WO2013087316A3 (en) Hair treatment agents comprising specific polymers
RU2017123388A (en) Peptides and their use in skin care
AR086168A1 (en) PROCESSES FOR THE ELABORATION OF MACROCICLICAL AND INTERMEDIARY DEPSIPEPTIDES
AU2015275248B2 (en) Legumain activated doxorubicin derivative as well as preparation method and application thereof
EA201391387A1 (en) NEUROPROTECTIVE PEPTIDES
NZ711281A (en) Short bio-active peptides for promoting wound healing
IN2015DN02104A (en)
BR112012017093A2 (en) organic compounds for the regulation of vector ion channels
BR112013024572A2 (en) A cosmetic process for treating and / or preventing oily or oily skin and / or associated aesthetic skin defects and cosmetic use of at least one compound of formula
WO2011125040A3 (en) New polyterpene type compounds, compositions containing them and topical uses thereof
WO2010112712A3 (en) Novel proteasome-activating anti-aging peptides and compositions containing same
GB201018125D0 (en) Peptide
WO2010063953A3 (en) Novel amino c-xyloside compounds, and cosmetic use
WO2014204229A3 (en) Pharmaceutical composition for preventing or treating rheumatoid arthritis, comprising peptide as active ingredient

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 12726879

Country of ref document: EP

Kind code of ref document: A2